Login to Your Account



Other News To Note


Thursday, May 10, 2012
• China Nuokang Bio-Pharmaceutical Inc., of Beijing, received a proposal from its chairman and CEO, Baizhong Xue, to take the company private by acquiring all outstanding shares for $5.80 per American Depositary Share. Each Nuokang ADS represents eight Nuokang ordinary shares.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription